Adverse events63

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 63

Type	Event	Organ system	Group	Affected	At risk	Events
other	Metabolic acidosis	Metabolism and nutrition disorders	Zibotentan 0.25 mg + Dapagliflozin	5	91	5
other	Metabolic acidosis	Metabolism and nutrition disorders	Zibotentan 1.5 mg + Dapagliflozin	7	179	8
other	Metabolic acidosis	Metabolism and nutrition disorders	Placebo + Dapagliflozin	2	177	2
other	Headache	Nervous system disorders	Zibotentan 0.25 mg + Dapagliflozin	6	91	6
other	Headache	Nervous system disorders	Zibotentan 1.5 mg + Dapagliflozin	8	179	9
other	Headache	Nervous system disorders	Placebo + Dapagliflozin	2	177	2
other	Hypertension	Vascular disorders	Zibotentan 0.25 mg + Dapagliflozin	5	91	5
other	Hypertension	Vascular disorders	Zibotentan 1.5 mg + Dapagliflozin	0	179	0
other	Hypertension	Vascular disorders	Placebo + Dapagliflozin	1	177	1
other	Brain natriuretic peptide increased	Investigations	Zibotentan 0.25 mg + Dapagliflozin	2	91	2
other	Brain natriuretic peptide increased	Investigations	Zibotentan 1.5 mg + Dapagliflozin	9	179	9
other	Brain natriuretic peptide increased	Investigations	Placebo + Dapagliflozin	1	177	1
serious	Gastroenteritis	Infections and infestations	Zibotentan 0.25 mg + Dapagliflozin	0	91	0
serious	Gastroenteritis	Infections and infestations	Zibotentan 1.5 mg + Dapagliflozin	0	179	0
serious	Gastroenteritis	Infections and infestations	Placebo + Dapagliflozin	1	177	1
serious	Restlessness	Psychiatric disorders	Zibotentan 0.25 mg + Dapagliflozin	0	91	0
serious	Restlessness	Psychiatric disorders	Zibotentan 1.5 mg + Dapagliflozin	0	179	0
serious	Restlessness	Psychiatric disorders	Placebo + Dapagliflozin	1	177	1
serious	Cerebrovascular accident	Nervous system disorders	Zibotentan 0.25 mg + Dapagliflozin	0	91	0
serious	Cerebrovascular accident	Nervous system disorders	Zibotentan 1.5 mg + Dapagliflozin	1	179	1

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04724837/events

API reference For AI assistants

Adverse events63

Sources 3

Read this list from software.